Anti-TNF levels and anti-drug antibodies, immunosuppressants and clinical outcomes in inflammatory bowel disease.
about
Posttranslational Modifications and the Immunogenicity of BiotherapeuticsIncidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview.Optimizing pharmacologic management of inflammatory bowel disease.Therapeutic Drug Monitoring and Clinical Outcomes in Immune Mediated Diseases: The Missing Link.Mucosal Healing in Ulcerative Colitis: A Comprehensive Review.
P2860
Anti-TNF levels and anti-drug antibodies, immunosuppressants and clinical outcomes in inflammatory bowel disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Anti-TNF levels and anti-drug ...... in inflammatory bowel disease.
@en
type
label
Anti-TNF levels and anti-drug ...... in inflammatory bowel disease.
@en
prefLabel
Anti-TNF levels and anti-drug ...... in inflammatory bowel disease.
@en
P2093
P2860
P921
P1476
Anti-TNF levels and anti-drug ...... in inflammatory bowel disease.
@en
P2093
Asher Kornbluth
Christina Ha
Jagrati Mathur
P2860
P304
P356
10.1586/17474124.2015.983079
P577
2015-01-20T00:00:00Z